0 By PRISM In articlePosted August 28, 2017MDMA designated as ‘breakthrough therapy’In a press release dated 26 August 2017, the Multidisciplinary Association for Psychedelic Studies (MAPS) announced that the US Food and Drug Administration has granted ‘Breakthrough [...] READ MORE
0 By PRISM In articlePosted October 7, 2013PRISM Goes America: Psychedelic Science 2013By PRISM President Martin Williams PhD READ MORE